Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
May 27, 2016
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer
|
April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
Human Molecular Genetics
|
September 1, 1995
Candidate regions for a testicular cancer susceptibility gene
M G Leahy, S Tonks, J H Moses, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 26, 2022
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy
S E Alexander, H A McNair, U Oelfke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 26, 2021
The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance
A Webster, S Hafeez, R Lewis, et al.
Clinical and Translational Radiation Oncology
|
May 16, 2022
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
A Mitchell, M Ingle, G Smith, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 9, 2022
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis
S Hafeez, M Koh, K Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)
J Shamash, S-J Sarker, R Huddart, et al.
ESMO Open
|
March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study
E Sherman, J L Lee, P R Debruyne, et al.
Prostate Cancer and Prostatic Diseases
|
September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
May 27, 2016
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer
|
April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
Human Molecular Genetics
|
September 1, 1995
Candidate regions for a testicular cancer susceptibility gene
M G Leahy, S Tonks, J H Moses, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 26, 2022
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy
S E Alexander, H A McNair, U Oelfke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 26, 2021
The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance
A Webster, S Hafeez, R Lewis, et al.
Clinical and Translational Radiation Oncology
|
May 16, 2022
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
A Mitchell, M Ingle, G Smith, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 9, 2022
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis
S Hafeez, M Koh, K Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)
J Shamash, S-J Sarker, R Huddart, et al.
ESMO Open
|
March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study
E Sherman, J L Lee, P R Debruyne, et al.
Prostate Cancer and Prostatic Diseases
|
September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, et al.
Page
of 9